Sutura Announces Initial Product Launch Of The 12F Superstitch Vascular Suturing Device

Como, Italy - Sutura, Inc., an innovative developer of minimally invasive vascular suturing devices, announced recently the initial product launch of the Company's 12F SuperStitch suturing device. Dr. Mario Galli performed multiple successful procedures recently using the 12F SuperStitch at Santa Ana Hospital in Como Italy. Dr. Galli performed 14, 18 & 24F closures using a 12F SuperStitch placing multiple sutures in the femoral artery with, in each case, the device successfully closing the arteriotomy.

"The results of the initial launch of the 12F device, the only device that can close large bore holes in vessels, are yet another important milestone for Sutura," said Anthony Nobles, PhD, Sutura's Chief Science Officer.

Sutura believes that these successful initial cases of the 12F device will only add to the positive feedback the SuperStitch product line has received to date.

Dr. Galli, speaking from Como, Italy, added, "We are very pleased to have had the opportunity to perform these procedures for the first time here in Italy as we did with Sutura's 6 and 8F SuperStitch devices.

Dr. Nobles further commented that Dr. Galli has been a crucial component in the development of the SuperStitch technology as he has performed many cases using the SuperStitch and is in the process of completing a 100 patient study for Sutura with initial results that are demonstrating positive outcomes for the SuperStitch products.

"I believe the SuperStitch device for closing large bore holes is superior to any competitive technologies I have worked with and I feel that this device can become the Gold Standard for closure of large diameter holes," noted Dr. Galli.

SOURCE: Sutura, Inc.